Terms: = Kidney tumors AND TNFRSF17, BCMA, 608, ENSG00000048462, CD269, Q02223, BCM
54 results:
1. Association of spironolactone use with risk of urinary tract cancer in the general population: A matched population-based cohort study.
Chen LC; Yang HJ; Yu BH; Lee MS; Lin HY; Chiou WY; Liu DW; Hsu FC; Chew CH; Hung SK
PLoS One; 2024; 19(3):e0300391. PubMed ID: 38536840
[TBL] [Abstract] [Full Text] [Related]
2. Using Comparative Proteomics to Identify Protein Signatures in Clear Cell Renal Cell Carcinoma.
Park J; Lee EH; Sim H; Na AY; Choi SY; Chung JW; Ha YS; Kwon TG; Lee S; Lee JN
Cancer Genomics Proteomics; 2023; 20(6):592-601. PubMed ID: 37889066
[TBL] [Abstract] [Full Text] [Related]
3. Cadherin-16 (CDH16) immunohistochemistry: a useful diagnostic tool for renal cell carcinoma and papillary carcinomas of the thyroid.
Lennartz M; Csomós H; Chirico V; Weidemann S; Gorbokon N; Menz A; Büscheck F; Hube-Magg C; Höflmayer D; Bernreuther C; Blessin NC; Lebok P; Sauter G; Steurer S; Burandt E; Dum D; Krech T; Simon R; Minner S; Jacobsen F; Clauditz TS; Luebke AM; Siraj AK; Al-Dayel F; Al-Kuraya KS; Hinsch A
Sci Rep; 2023 Aug; 13(1):12917. PubMed ID: 37558687
[TBL] [Abstract] [Full Text] [Related]
4. Multimodal recurrence scoring system for prediction of clear cell renal cell carcinoma outcome: a discovery and validation study.
Gui CP; Chen YH; Zhao HW; Cao JZ; Liu TJ; Xiong SW; Yu YF; Liao B; Cao Y; Li JY; Huang KB; Han H; Zhang ZL; Chen WF; Jiang ZY; Gao Y; Han GP; Tang Q; Ouyang K; Qu GM; Wu JT; Guo JP; Li CX; Li PX; Liu ZP; Hsieh JT; Cai MY; Li XS; Wei JH; Luo JH
Lancet Digit Health; 2023 Aug; 5(8):e515-e524. PubMed ID: 37393162
[TBL] [Abstract] [Full Text] [Related]
5. Trends in Survival and Surgical Methods in Patients Surgically Treated for Metastatic Spinal tumors: 25-Year Experience in a Single Institution.
Park SJ; Park JS; Lee CS; Kang BJ; Jung CW
Clin Orthop Surg; 2023 Feb; 15(1):109-117. PubMed ID: 36778984
[TBL] [Abstract] [Full Text] [Related]
6. FABP1 expression in human tumors: a tissue microarray study on 17,071 tumors.
Dum D; Ocokoljic A; Lennartz M; Hube-Magg C; Reiswich V; Höflmayer D; Jacobsen F; Bernreuther C; Lebok P; Sauter G; Luebke AM; Burandt E; Marx AH; Simon R; Clauditz TS; Minner S; Menz A; Büscheck F; Gorbokon N; Steurer S; Blessin NC; Krech T
Virchows Arch; 2022 Dec; 481(6):945-961. PubMed ID: 35951102
[TBL] [Abstract] [Full Text] [Related]
7. Pan-keratin Immunostaining in Human tumors: A Tissue Microarray Study of 15,940 tumors.
Menz A; Gorbokon N; Viehweger F; Lennartz M; Hube-Magg C; Hornsteiner L; Kluth M; Völkel C; Luebke AM; Fraune C; Uhlig R; Minner S; Dum D; Höflmayer D; Sauter G; Simon R; Burandt E; Clauditz TS; Lebok P; Jacobsen F; Steurer S; Krech T; Marx AH; Bernreuther C
Int J Surg Pathol; 2023 Sep; 31(6):927-938. PubMed ID: 35946088
[TBL] [Abstract] [Full Text] [Related]
8. SATB2 Expression in Human tumors: A Tissue Microarray Study on More Than 15 000 tumors.
Dum D; Kromm D; Lennartz M; De Wispelaere N; Büscheck F; Luebke AM; Burandt E; Menz A; Kluth M; Hube-Magg C; Hinsch A; Höflmayer D; Weidemann S; Fraune C; Möller K; Lebok P; Sauter G; Simon R; Uhlig R; Wilczak W; Minner S; Krech R; Bernreuther C; Marx A; Steurer S; Jacobsen F; Clauditz T; Krech T
Arch Pathol Lab Med; 2023 Apr; 147(4):451-464. PubMed ID: 35917493
[TBL] [Abstract] [Full Text] [Related]
9. An MRI-based radiomics model to predict clear cell renal cell carcinoma growth rate classes in patients with von Hippel-Lindau syndrome.
Anari PY; Lay N; Gopal N; Chaurasia A; Samimi S; Harmon S; Firouzabadi FD; Merino MJ; Wakim P; Turkbey E; Jones EC; Ball MW; Turkbey B; Linehan WM; Malayeri AA
Abdom Radiol (NY); 2022 Oct; 47(10):3554-3562. PubMed ID: 35869307
[TBL] [Abstract] [Full Text] [Related]
10. Weight-change trajectory in relation to cancer risk: findings from a nationwide cohort study in South Korea.
Tran TPT; Luu NM; Bui TT; Han M; Lim MK; Oh JK
Obesity (Silver Spring); 2022 Jul; 30(7):1507-1519. PubMed ID: 35785482
[TBL] [Abstract] [Full Text] [Related]
11. Prevalence of SWI/SNF genomic alterations in cancer and association with the response to immune checkpoint inhibitors: A systematic review and meta-analysis.
Wang N; Qin Y; Du F; Wang X; Song C
Gene; 2022 Aug; 834():146638. PubMed ID: 35680019
[TBL] [Abstract] [Full Text] [Related]
12. A web-based prognostic nomogram for the cancer specific survival of elderly patients with T1-T3N0M0 renal pelvic transitional cell carcinoma based on the surveillance, epidemiology, and end results database.
Wang J; Tang J; Liu X; He D
BMC Urol; 2022 May; 22(1):78. PubMed ID: 35610606
[TBL] [Abstract] [Full Text] [Related]
13. Fine needle aspiration of hepatic angiomyolipoma with extramedullary hematopoiesis: A case report.
Baumgartner E; Garapati M; Sanders R; Eloubeidi M; Rosenblum F
Cytopathology; 2022 Jul; 33(4):534-539. PubMed ID: 35075721
[TBL] [Abstract] [Full Text] [Related]
14. Characteristics, risk factors, and outcomes associated with readmission in COVID-19 patients: A systematic review and meta-analysis.
Akbari A; Fathabadi A; Razmi M; Zarifian A; Amiri M; Ghodsi A; Vafadar Moradi E
Am J Emerg Med; 2022 Feb; 52():166-173. PubMed ID: 34923196
[TBL] [Abstract] [Full Text] [Related]
15. The association between antibiotic use and survival in renal cell carcinoma patients treated with immunotherapy: a multi-center study.
Guven DC; Acar R; Yekeduz E; Bilgetekin I; Baytemur NK; Erol C; Ceylan F; Sendur MA; Demirci U; Urun Y; Karadurmus N; Erman M; Kilickap S
Curr Probl Cancer; 2021 Dec; 45(6):100760. PubMed ID: 34130864
[TBL] [Abstract] [Full Text] [Related]
16. Challenges of early renal cancer detection: symptom patterns and incidental diagnosis rate in a multicentre prospective UK cohort of patients presenting with suspected renal cancer.
Vasudev NS; Wilson M; Stewart GD; Adeyoju A; Cartledge J; Kimuli M; Datta S; Hanbury D; Hrouda D; Oades G; Patel P; Soomro N; Sullivan M; Webster J; Selby PJ; Banks RE
BMJ Open; 2020 May; 10(5):e035938. PubMed ID: 32398335
[TBL] [Abstract] [Full Text] [Related]
17. Identification of diagnostic metabolic signatures in clear cell renal cell carcinoma using mass spectrometry imaging.
Vijayalakshmi K; Shankar V; Bain RM; Nolley R; Sonn GA; Kao CS; Zhao H; Tibshirani R; Zare RN; Brooks JD
Int J Cancer; 2020 Jul; 147(1):256-265. PubMed ID: 31863456
[TBL] [Abstract] [Full Text] [Related]
18. UK Multicenter Prospective Evaluation of the Leibovich Score in Localized Renal Cell Carcinoma: Performance has Altered Over Time.
Vasudev NS; Hutchinson M; Trainor S; Ferguson R; Bhattarai S; Adeyoju A; Cartledge J; Kimuli M; Datta S; Hanbury D; Hrouda D; Oades G; Patel P; Soomro N; Stewart GD; Sullivan M; Webster J; Messenger M; Selby PJ; Banks RE
Urology; 2020 Feb; 136():162-168. PubMed ID: 31705948
[TBL] [Abstract] [Full Text] [Related]
19. Geographic distribution and risk of upper urothelial carcinomas in Croatia, 2001-2011.
Medunjanin D; Sonicki Z; Vena JE; Cvitkovic A; Robb SW
BMC Cancer; 2019 Oct; 19(1):950. PubMed ID: 31615453
[TBL] [Abstract] [Full Text] [Related]
20. Advancing Pan-cancer Gene Expression Survial Analysis by Inclusion of Non-coding RNA.
Ye B; Shi J; Kang H; Oyebamiji O; Hill D; Yu H; Ness S; Ye F; Ping J; He J; Edwards J; Zhao YY; Guo Y
RNA Biol; 2020 Nov; 17(11):1666-1673. PubMed ID: 31607216
[TBL] [Abstract] [Full Text] [Related]
[Next]
